Key facts
| Price (PPV) | 25,682 MAD |
|---|---|
| Dispensing status | Schedule A — prescription only |
| Composition (DCI) | binimetinib |
| Class | Antineoplastic agents |
| ATC code | L01EE03 |
| Manufacturer | PFIZER MAROC |
| Presentation | Boite de 84 |
| Hospital price | 25,186 MAD |
| Data collected on | 9/8/2026 |
Indications
Le binimetinib en association à l’encorafenib est indiqué dans le traitement de patients adultes atteints de mélanome non résécable ou métastatique porteur d’une mutation BRAF V600.
Find an open pharmacy
On-call pharmacies near you
About Mektovi 15 mg
Mektovi 15 mg belongs to the antineoplastic agents therapeutic class. In Morocco, this drug is marketed by PFIZER MAROC and is among the pharmaceutical specialties referenced by the Ministry of Health.
For any question about the use, effects, or drug interactions of Mektovi 15 mg, consult your doctor or pharmacist. This information is provided for educational purposes and does not replace medical advice.
Frequently Asked Questions about Mektovi 15 mg
Answers to common questions from Moroccan patients about this drug.